account_balance
Investment manager · 13F filer · SEC CIK 200406
Johnson & Johnson
Reported value$762Mas of Sep 30, 2026
Positions15 0 new, 0 sold out
Top 10 weight99%PTGX alone is 45%
FiledOct 2626 days after quarter end
Portfolio · as of Sep 30, 2026
Where the money is
New or addedTrimmedHeld
PTGX
Protagonist Therapeutics INC
45.3%
NBTX
Nanobiotix
23.0%
MGTX
Meiragtx Hldgs PLC
9.6%
RAPP
Rapport Therapeutics INC
7.9%
CTNM
Contineum Therapeutics INC
3.5%
CBRS
Cerebras Systems INC
3.0%Added
XNCR
Xencor INC
2.5%
LEGN
Legend Biotech Corp
2.1%
FATE
1.1%
CVRX
0.9%
5 others
1.2%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed